- Email: [email protected]
TRENDS IN PULMONARY HYPERTENSION HOSPITALIZATIONS: INSIGHTS FROM A NATIONAL DATABASE
1910 JACC March 21, 2017 Volume 69, Issue 11
Pulmonary Hypertension and Venous Thrombo-embolic Disease TRENDS IN PULMONARY HYPERTENSION HOSPITALIZATIONS: INSIGHTS FROM A NATIONAL DATABASE Poster Contributions Poster Hall, Hall C Saturday, March 18, 2017, 3:45 p.m.-4:30 p.m. Session Title: Predicting the Future: Observations and Discoveries From Registries and Databases Abstract Category: 35. Pulmonary Hypertension and Pulmonary Thrombo-embolic Disease
Presentation Number: 1230-004
Authors: Mohit Pahuja, Ronak Soni, Aman Handa, Suman Misra, Smit Patel, Neel Patel, Dhara Patel, Jeremy Feldman, St. Joseph’s Hospital and Medical Center, Phoenix, AZ, USA
Background: Pulmonary hypertension (PH) is a serious unrelenting disorder that affects the functionality and quality of life of patients in addition to significantly decreasing their life span. The true prevalence of PH in general population is unknown. We evaluated hospitalization (HOSP) trends of PH from a large national database in the past decade.
Methods: We studied the trends for PH HOSP using data from the 2000-2010 Nationwide Inpatient Sample (NIS) database. PH related HOSP were identified using primary discharge diagnosis ICD-9 codes 416, 416.8 and 416.9. We sub-divided the number of HOSP into idiopathic primary pulmonary hypertension (PPH) defined by ICD -9 code 416.0 and codes 416.8 and 416.9 for secondary pulmonary hypertension (SPH).
Results: There were an estimated 1, 56,948 HOSP with PH in the US from 2000-2010. The PH HOSP rate increased from 207 to 243 per 1 million US populations (relative increase: 14.8 %, p = 0.014) from 2000 to 2010. We also noted that the number of admissions for PPH dropped from 103 to 27 (relative decrease: 73.8 %, p = 0.005) and with SPH increased from 105 to 216 (relative increase: 51.4 %, p = 0.001) as shown in Figure 1.
Conclusion: There was increase in the rates of PH and SPH, but the number of HOSP dropped for PPH. During this same time period the availability of effective treatments for PPH emerged which have decreased its HOSP rate. In contrast SPH remain without any effective treatment option. Prevention of PH related HOSP would result in major cost saving in healthcare system.
Pulmonary Hypertension and Venous Thrombo-embolic Disease TRENDS IN PULMONARY HYPERTENSION HOSPITALIZATIONS: INSIGHTS FROM A NATIONAL DATABASE Poster Contributions Poster Hall, Hall C Saturday, March 18, 2017, 3:45 p.m.-4:30 p.m. Session Title: Predicting the Future: Observations and Discoveries From Registries and Databases Abstract Category: 35. Pulmonary Hypertension and Pulmonary Thrombo-embolic Disease
Presentation Number: 1230-004
Authors: Mohit Pahuja, Ronak Soni, Aman Handa, Suman Misra, Smit Patel, Neel Patel, Dhara Patel, Jeremy Feldman, St. Joseph’s Hospital and Medical Center, Phoenix, AZ, USA
Background: Pulmonary hypertension (PH) is a serious unrelenting disorder that affects the functionality and quality of life of patients in addition to significantly decreasing their life span. The true prevalence of PH in general population is unknown. We evaluated hospitalization (HOSP) trends of PH from a large national database in the past decade.
Methods: We studied the trends for PH HOSP using data from the 2000-2010 Nationwide Inpatient Sample (NIS) database. PH related HOSP were identified using primary discharge diagnosis ICD-9 codes 416, 416.8 and 416.9. We sub-divided the number of HOSP into idiopathic primary pulmonary hypertension (PPH) defined by ICD -9 code 416.0 and codes 416.8 and 416.9 for secondary pulmonary hypertension (SPH).
Results: There were an estimated 1, 56,948 HOSP with PH in the US from 2000-2010. The PH HOSP rate increased from 207 to 243 per 1 million US populations (relative increase: 14.8 %, p = 0.014) from 2000 to 2010. We also noted that the number of admissions for PPH dropped from 103 to 27 (relative decrease: 73.8 %, p = 0.005) and with SPH increased from 105 to 216 (relative increase: 51.4 %, p = 0.001) as shown in Figure 1.
Conclusion: There was increase in the rates of PH and SPH, but the number of HOSP dropped for PPH. During this same time period the availability of effective treatments for PPH emerged which have decreased its HOSP rate. In contrast SPH remain without any effective treatment option. Prevention of PH related HOSP would result in major cost saving in healthcare system.